Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (361-370 of 606) with videos related to

Pageof 61
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|July 1, 2005
Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptorHeng Xu, Xiaoying Wang, Darin Zimmerman, et al.
Neuropeptides|June 1, 1985
Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding siteR B Rothman, J A Danks, M Herkenham, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1989
Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramineC Benkelfat, C S Aulakh, V Bykov, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesisXiaoxue Qiu, Guijie Guo, Ke Chen, et al.
Synapse (New York, N.Y.)|September 16, 2010
Evidence for noncompetitive modulation of substrate-induced serotonin releaseRichard B Rothman, Michael H Baumann, Bruce E Blough, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2006
Interaction of amphetamines and related compounds at the vesicular monoamine transporterJohn S Partilla, Allison G Dempsey, Ameet S Nagpal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 22, 2004
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')Michael H Baumann, Robert D Clark, Allison G Budzynski, et al.
Biological Psychiatry|December 1, 1995
Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusersM H Baumann, T M Gendron, K M Becketts, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinansSubramaniam Ananthan, Naveen K Khare, Surendra K Saini, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporterDavid Lewis, Ying Zhang, Thomas Prisinzano, et al.
Pageof 61

Showing results (361-370 of 606) with videos related to

Sort By:
Pageof 61
The Journal of Pharmacology and Experimental Therapeutics|July 1, 2005
Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptorHeng Xu, Xiaoying Wang, Darin Zimmerman, et al.
Neuropeptides|June 1, 1985
Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding siteR B Rothman, J A Danks, M Herkenham, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1989
Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramineC Benkelfat, C S Aulakh, V Bykov, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesisXiaoxue Qiu, Guijie Guo, Ke Chen, et al.
Synapse (New York, N.Y.)|September 16, 2010
Evidence for noncompetitive modulation of substrate-induced serotonin releaseRichard B Rothman, Michael H Baumann, Bruce E Blough, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2006
Interaction of amphetamines and related compounds at the vesicular monoamine transporterJohn S Partilla, Allison G Dempsey, Ameet S Nagpal, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 22, 2004
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy')Michael H Baumann, Robert D Clark, Allison G Budzynski, et al.
Biological Psychiatry|December 1, 1995
Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusersM H Baumann, T M Gendron, K M Becketts, et al.
Bioorganic & Medicinal Chemistry|August 21, 2003
Novel ligands for the opioid receptors: synthesis and structure-activity relationships among 5'-aryl and 5'-heteroaryl 17-cyclopropylmethyl-4,5 alpha-epoxypyrido[2',3':6,7]morphinansSubramaniam Ananthan, Naveen K Khare, Surendra K Saini, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Further exploration of 1-[2-[Bis-(4-fluorophenyl)methoxy]ethyl]piperazine (GBR 12909): role of N-aromatic, N-heteroaromatic, and 3-oxygenated N-phenylpropyl substituents on affinity for the dopamine and serotonin transporterDavid Lewis, Ying Zhang, Thomas Prisinzano, et al.
Pageof 61